DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Neon Therapeutics Q4 EPS $(0.63) Misses $(0.62) Estimate

Neon Therapeutics (NASDAQ:NTGN) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.62) by 1.61 percent. This is a 25 percent increase over losses of $(0.84) per share from

Benzinga · 03/02/2020 12:13

Neon Therapeutics (NASDAQ:NTGN) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.62) by 1.61 percent. This is a 25 percent increase over losses of $(0.84) per share from the same period last year.